Studies have indicated that HFS might result from inhibition of targeted receptors in healthy tissue by anti-angiogenic agents, revealing potential effectiveness of VEGF/VEGFR blockade (35, 36). This evidence concerns the gene KDR and Hand-foot syndrome.